Lyell Immunopharma shares owned by TD Asset Management
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by TD Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $643k | 1.0M | 0.64 |
| 2024-09-30 | $1.5M | 1.0M | 1.51 |
| 2024-06-30 | $1.5M | 1.0M | 1.45 |
| 2024-03-31 | $2.1M | 964k | 2.23 |
| 2023-12-31 | $1.8M | 916k | 1.94 |
| 2023-09-30 | $1.3M | 916k | 1.47 |
| 2023-06-30 | $1.4M | 432k | 3.18 |
| 2023-03-31 | $424k | 180k | 2.36 |
| 2022-12-31 | $624k | 180k | 3.47 |
| 2022-09-30 | $1.3M | 180k | 7.41 |
| 2022-06-30 | $1.2M | 180k | 6.52 |
| 2022-03-31 | $907k | 180k | 5.05 |
| 2021-12-31 | $1.3M | 169k | 7.74 |
| 2021-09-30 | $1.7M | 113k | 14.80 |
| 2021-06-30 | $1.3M | 87k | 14.50 |